Cronos Group Inc. (CRON) Form 8-K — Nov 5, 2026
Cronos Group reported Q3 2026 net revenue of $63.5 million, up 75% year-over-year (73% constant currency), with record net revenue, gross profit of $32.3 million (50.9% margin), and Adjusted EBITDA of $17.1 million, up 201% YoY. Growth was led by Canadian flower and extract sales under the Spinach brand — #1 in Canadian vapes and edibles — plus an eleventh consecutive record quarter in Israel and a 614% YoY surge in international revenue ex-Israel, driven by Germany. Net income fell 37% YoY to $17.8 million due to lower other income and higher opex, but the company retains $840.6 million in cash and investments and repurchased 15.5 million shares for $42.3 million year-to-date.
Key figures
- Eps
- 0.04
- Revenue
- 63450000
- Guidance
- No quantitative guidance provided in the release.
- Net Income
- 17826000
- Revenue Yoy
- 75% (Q3 2026 vs Q3 2025); 73% on a constant-currency organic basis
- Total Assets
- 1198009000
- Cash Position
- 840629000
- Shares Outstanding
- 367528366
- Capex q3 2026
- 9949000
- Canada revenue q3
- 35133000
- Israel revenue q3
- 15088000
- Gross margin q3 2026
- 50.9%
- Gross profit q3 2026
- 32283000
- Q3 share repurchases
- 3.2 million shares for $9.4 million
- Nine month net income
- 69200000
- Ytd share repurchases
- 15.5 million shares for $42.3 million
- Nine month net revenue
- 161667000
- Adjusted ebitda q3 2026
- 17076000
- Adjusted ebitda yoy change
- +201% ($11.4M improvement)
- Nine month adjusted ebitda
- 35243000
- Other countries revenue q3
- 13229000
- Nine month operating cash flow
- 69244000
- Intl ex israel revenue growth q3
- 614% YoY
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.